Home › Anemia › North Carolina › Winston-Salem
Anemia clinical trials in Winston-Salem, NC
4 studies for Anemia are looking for participants at sites in and around Winston-Salem (within about 30 miles). Open a study to see who can join and how to contact the study team.
Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia
RecruitingPhase 1/2
- Atrium Health Wake Forest Baptist, Winston-Salem
A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
RecruitingPhase 3
- Novant Health Care Institute, Winston-Salem
A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib
RecruitingPhase 3
- Novant Health, Winston-Salem
A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
RecruitingPhase 3
- Novant Health-Cancer Institute, Winston-Salem
About Anemia
Anemia occurs when your blood doesn't carry enough oxygen to the rest of your body. Read about conditions that lead to it and treatments available.
More about Anemia on MedlinePlus
Anemia trials in other cities
- New York City, NY7 studies
- Atlanta, GA6 studies
- Philadelphia, PA6 studies
- Miami, FL6 studies
- Houston, TX5 studies
- Tampa, FL5 studies
- St. Louis, MO4 studies
- Cleveland, OH4 studies
- Baldwin Park, CA4 studies
- Queens, NY3 studies
- Edison, NJ3 studies
- Los Angeles, CA3 studies
Other studies in Winston-Salem
- Cancer (all types)19 studies
- Acute Myeloid Leukemia18 studies
- Multiple Myeloma14 studies
- Cardiovascular Disease14 studies
- Breast Cancer14 studies
- Non-Small Cell Lung Cancer12 studies
- Ovarian Cancer10 studies
- COPD9 studies
- Type 2 Diabetes9 studies
- Myelodysplastic Syndromes9 studies
- Lung Cancer8 studies
- Chronic Lymphocytic Leukemia8 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.